Aureus
AExcellent

Gilead Sciences, Inc.(GILD)

A

Financial data as of Dec 31, 2024Stable · Healthcare

FCF Margin35.8%Free Cash Flow / Revenue
Cash Conversion—Operating CF / Net Income
Free Cash Flow$10.3B
Revenue$28.8B
Net Cash-$16.7BNet debt position
Debt / FCF2.6xManageable debt load
Current Ratio1.60Adequate short-term liquidity
YoY FCF Growth-5.0%5 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseA
→
+0.5Healthy FCF margin with manageable debt (35.8%, 2.6x)
→
FinalA

Analysis Summary

Strengths

  • Exceptional FCF margin (35.8%)

Concerns

  • Net debt position ($16.7B)
Cash conversion ratio unavailable or not meaningful

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin35.8%
Net Margin1.7%
Operating CF Margin37.7%
CapEx Ratio1.8%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$16.7BNet debt position
Debt / FCF2.6xManageable debt load
Current Ratio1.60Strong liquidity
Debt / Equity1.38Moderate leverage

Quarterly FCF Trend

-5.0% YoYStable (-5.0%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NameGilead Sciences, Inc.
SectorHealthcare
Free Cash Flow$10.3B
Revenue$28.8B
Net Income$480.0M
Operating Cash Flow$10.8B
Capital Expenditure$523.0M
FCF Margin35.8%
Cash Conversion Rate—
Net Margin1.7%
Total Debt$26.7B
Total Cash$10.0B
Net Cash-$16.7B
Current Ratio1.60
Debt / Equity1.38
Debt / FCF2.6x
YoY FCF Growth-5.0%
Positive Quarters5 of 5
Trend DirectionStable
Report DateDec 31, 2024
GradeA
Data SourceYahoo Finance

Related Research

All research →
Sector Report4 min read

Healthcare: Eleven A-Grades and Three Falling Giants

The healthcare sector splits into two groups: companies printing cash and insurers bleeding it. The trend breakdown tells you which side is winning.

Feb 13, 2026
GILDREGNZTSISRG+11